| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |